IP Library Granted Patent US 10,172,784
Granted Patent B2
US 10,172,784 · App. 14/366,968 · Granted Jan 8, 2019

Bioactive compositons having skin anti aging activity

Inventors: Olga V. Dueva-Koganov (White Plains, NY); Michael Koganov (White Plains, NY); Jeanette Richards (Liberty Township, OH); Tom Dawson (Hamilton, OH); Mary Jane Combs (Covington, KY)
Assignee: ISP INVESTMENTS LLC
A61K8/97A61K8/9711A61K8/9789A61Q19/04A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,172,784
App. No.
14/366,968
Granted
Jan 8, 2019
Kind
B2
Abstract

The present invention relates to bioactive compositions comprising blends of camellia and feverfew serum fractions and/or kelp and parsley serum fractions.

Claims (29)

1. A bioactive composition having anti-aging activity, said bioactive composition comprising:

a. an effective amount of:

i. a first composition comprising a combination of a camellia serum fraction and a feverfew serum fraction in a weight ratio of 10:90 to about 90:10; and/or

ii. a second composition comprising a combination of a parsley serum fraction and a kelp serum fraction in a weight ratio of 10:90 to about 90:10.

2. The bioactive composition of claim 1 , wherein the first composition comprises:

a. from about 0.001 wt % to about 15 wt % of the camellia serum fraction; and

b. from about 0.001 wt % to about 15 wt % of the feverfew serum fraction, wherein the wt % is based on the total weight of the composition.

3. The bioactive composition of claim 2 , wherein a weight ratio of the camellia serum fraction to the feverfew serum fraction ranges from about 20:80 to about 80:20.

4. The bioactive composition of claim 2 , wherein a weight ratio of the camellia serum fraction to the feverfew serum fraction is about 50:50 to about 80:20.

5. The bioactive composition of claim 2 , further comprising a thickening agent.

6. The bioactive composition of claim 1 , wherein a weight ratio of the parsley serum fraction to the kelp serum fraction ranges from about 30:70 to about 70:30.

7. The bioactive composition of claim 1 , wherein a weight ratio of the parsley serum fraction to the kelp serum fraction is about 50:50.

8. The bioactive composition of claim 1 , further comprising a thickening agent.

9. The bioactive composition of claim 1 comprising a combination of the first composition and the second composition.

10. The bioactive composition of claim 9 , wherein the first composition comprises:

a. from about 0.001 wt % to about 15 wt % of the camellia serum fraction, and

b. from about 0.001 wt % to about 15 wt % of the feverfew serum fraction; and wherein the second composition comprises:

c. from about 0.001 wt % to about 15 wt % of the parsely serum fraction, and

d. from about 0.001 wt % to about 15 wt % of the kelp serum fraction, wherein the wt % is based on the total weight of the composition.

11. The bioactive composition of claim 1 , wherein said bioactive composition further possesses one or more of the following properties: antioxidant and/or free radical scavenging, inhibition of enzymes associated with skin aging and environmental damage, skin protection, repair of human tissue or skin, UV protection, interruption of an inflammatory cycle, darkening regions of mammalian skin, reducing the appearance of skin hypopigmentation, stimulating one or more steps in melanin synthesis, protection from ozone and/or protection from osmotic shock.

12. The bioactive composition of claim 1 , wherein said anti-aging activity comprises hair and/or skin anti-aging activity.

13. The bioactive composition of claim 11 wherein said bioactive composition inhibits enzymes associated with skin aging and environmental damage.

14. The bioactive composition of claim 13 wherein said bioactive composition inhibits melanogenesis enzyme activity.

15. The bioactive composition of claim 13 wherein said bioactive composition inhibits trypsin activity, tyrosinase activity, or both.

16. The bioactive composition of claim 11 , wherein said composition increases anti-oxidant activity, free radical scavenging activity, or both.

17. The bioactive composition of claim 1 wherein said bioactive composition interrupts an inflammatory cycle.

18. The bioactive composition of claim 11 wherein said bioactive composition is effective in darkening regions of mammalian skin.

19. The bioactive composition of claim 11 wherein said bioactive composition is effective in reducing the appearance of skin hypopigmentation.

20. The bioactive composition of claim 11 wherein said bioactive composition is effective in stimulate one or more steps in melanin synthesis.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded May 24, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 042560/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2015
From: AKZO NOBEL SURFACE CHEMISTRY LLC; AKZO NOBEL CHEMICALS INTERNATIONA B.V.
To: ISP INVESTMENTS INC.
Reel/Frame 036583/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2014
From: DUEVA-KOGANOV, OLGA V.; KOGANOV, MICHAEL; RICHARDS, JEANETTE; DAWSON, TOM; COMBS, MARY JANE
To: AKZO NOBEL CHEMICALS INTERNATIONAL B.V.
Reel/Frame 033141/0362 →
Continuity (2)
Provisional Application 61579197 · Dec 22, 2011
Related Publication 20140348766A1 · Nov 27, 2014